Composition and method for modulating somatolactogenic function

Details Composition and method for modulating somatolactogenic function Composition and method for modulating somatolactogenic function

2005-03-15

2005-03-15

Tate, Christopher (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C530S350000, C530S399000

Reexamination Certificate

active

06867187

ABSTRACT:
A human prolactin-binding protein and compositions and methods using this protein are provided.

REFERENCES:
Amit et al., “Characterization of prolactin-and growth hormone-binding proteins in milk and their diversity among species”, 1997Mol. Cell. Endrocrinol.130: 167-180.
Barnard et al., “The serum growth hormone binding protein:pregnant with possibilities”, 1997J. Endocrinol153:1-14.
Baumann et al., A Specific Growth Hormone-Binding Protein in Human Plasma:Initial Characterization 1986J. Clin. Endocrinol. Metab.62:134-141.
Baumbach et al., “The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor”, 1989Genes Dev.3: 1199-1205.
Leav et al., “Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions”, 1999Am. J. Path.154:863-870.
Leung et al., “Growth hormone receptor and serum binding protein:purification, cloning and expression”, 1987Nature330:537-543.
Mercado et al., “A Growth Hormone-Prolactin-Binding Protein in Human Milk”, 1994J. Clin. Endocrinol. Metab.79(6):1637-1641.
Peeters et al., “A Growth Hormone Binding Factor in the Serum of Pregnant Mice”, 1977Endocrinology101:1164-1183.
Postel-Vinay et al., “Indentification of prolactin and growth hormone binding proteins in rabbit milk”, 1991Proc. Natl. Acad. Sci. USA88:6687-6690.
Sotiropoulos et al., “Evidence for Generation of the Growth Hormone-Binding Protein Through Proteolysis of the Growth Hormone Membrane Receptor”, 1993Endocrinology132(4):1863-1865.
Trivedi et al., “Release of Growth Hormone Binding Protein from IM-9 Lymphocytes by Endopeptidase is Dependent on Sulfydryl Group Inactivation”, 1988Endocrinology123(5):2201-2206.
Walker et al., “Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes” 1995Proc. Natl Acad. Sci. USA92:3278-3282.
Ymer et al., “Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum”, 1985Mol. Cell. Endocrinol.41:153-161.

Affiliated with

Also associated with

Rating

Composition and method for modulating somatolactogenic function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method for modulating somatolactogenic function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for modulating somatolactogenic function will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3380076